EYES RSI Chart
Last 7 days
11.1%
Last 30 days
8.7%
Last 90 days
85.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 512.5K | 0 | 0 | 475.0K |
2021 | 149.5K | 283.0K | 416.5K | 550.0K |
2020 | 2.3M | 1.1M | 0 | 16.0K |
2019 | 7.0M | 6.4M | 4.6M | 3.4M |
2018 | 7.9M | 7.6M | 8.2M | 6.9M |
2017 | 3.9M | 5.1M | 5.6M | 8.0M |
2016 | 8.3M | 6.7M | 5.6M | 4.0M |
2015 | 4.4M | 6.5M | 8.1M | 8.9M |
2014 | 2.0M | 2.5M | 2.9M | 3.4M |
2013 | 0 | 0 | 0 | 1.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 14, 2022 | williams gregg | bought | 200 | 2.00 | 100 | - |
Jun 13, 2022 | williams gregg | bought | 7,400 | 2.00 | 3,700 | - |
Jun 03, 2022 | williams gregg | bought | 9,748 | 2.4617 | 3,960 | - |
Jun 02, 2022 | williams gregg | bought | 245,722 | 2.3366 | 105,162 | - |
Jun 01, 2022 | williams gregg | bought | 299,282 | 2.2594 | 132,461 | - |
May 31, 2022 | williams gregg | bought | 174,447 | 2.33 | 74,870 | - |
May 24, 2022 | williams gregg | bought | 110,028 | 1.9847 | 55,438 | - |
May 23, 2022 | williams gregg | bought | 328,570 | 1.9656 | 167,160 | - |
May 20, 2022 | williams gregg | bought | 589,548 | 1.9163 | 307,649 | - |
May 19, 2022 | williams gregg | bought | 196,362 | 1.8049 | 108,794 | - |
Which funds bought or sold EYES recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Sep 09, 2022 | B. Riley Wealth Management, Inc. | new | - | 20.00 | 20.00 | -% |
Nov 04, 2021 | BBVA USA | sold off | -100 | -22,000 | - | -% |
Unveiling Second Sight Medical Products Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Second Sight Medical Products Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2022Q4 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 |
Revenue | - | - | - | - | - | - | - | - | 16.00 | 257 | 497 | 472 | 1,282 | 1,128 | 1,767 | 2,246 | 1,907 | 976 | 3,109 | 1,610 | 2,236 | 1,009 |
Gross Profit | - | - | - | 130 | - | - | - | 500 | - | - | 373 | 108 | 349 | 397 | 167 | 462 | 1,071 | 308 | 1,247 | 609 | -1,109 | -118 |
Operating Expenses | 99.6% | 7,797 | 3,907 | 4,124 | 3,485 | 2,296 | 2,843 | 1,774 | 3,116 | 8,904 | 8,499 | 7,727 | 8,790 | 10,165 | 9,044 | 9,008 | 9,059 | - | - | - | - | - |
S&GA Expenses | 174.3% | 3,369 | 1,228 | -766 | 617 | 1,338 | 2,472 | -1,289 | 1,516 | 701 | 1,001 | 1,308 | 1,689 | 2,103 | 2,406 | 3,040 | 2,879 | 3,011 | - | - | - | - |
R&D Expenses | 65.3% | 4,428 | 2,679 | 5,040 | 2,868 | 695 | 334 | 347 | 323 | 3,887 | 4,145 | 3,379 | 3,436 | 2,183 | 2,438 | 2,672 | 2,422 | - | - | - | - | - |
Net Income | -85.6% | -7,284 | -3,924 | -1,283 | -3,491 | -2,675 | -2,988 | -1,291 | -3,100 | -8,886 | -7,868 | -7,584 | -8,440 | -9,700 | -8,858 | -8,522 | -7,961 | - | - | - | - | - |
Net Income Margin | -31.8% | -29.24* | -22.19* | -18.98* | -25.08* | -30.24* | -60.08* | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -65.1% | -5,292 | -3,206 | -3,215 | -3,029 | -4,185 | -778 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 17.4% | 54.00 | 46.00 | 53.00 | 60.00 | 45.00 | 51.00 | 57.00 | 66.00 | 69.00 | 71.00 | 74.00 | 76.00 | 28.00 | 4.00 | 4.00 | 5.00 | 4.00 | 17.00 | 24.00 | 32.00 | 39.00 |
Current Assets | 36.6% | 32.00 | 23.00 | 31.00 | 36.00 | 41.00 | 48.00 | 54.00 | 57.00 | 60.00 | 2.00 | 73.00 | 75.00 | 28.00 | 4.00 | 3.00 | 5.00 | 4.00 | 13.00 | 20.00 | 28.00 | 35.00 |
Cash Equivalents | 43.5% | 30.00 | 21.00 | 25.00 | 32.00 | 38.00 | 45.00 | 52.00 | 56.00 | 60.00 | 2.00 | 1.00 | 74.00 | 27.00 | 2.00 | 2.00 | 4.00 | 2.00 | 11.00 | 18.00 | 25.00 | 32.00 |
Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 2.00 |
Net PPE | -2.3% | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 0.2% | 25.00 | 25.00 | 27.00 | 27.00 | 6.00 | 7.00 | 6.00 | 3.00 | 2.00 | 3.00 | 4.00 | 4.00 | 7.00 | 5.00 | 3.00 | 3.00 | 5.00 | 9.00 | 10.00 | 10.00 | 10.00 |
Current Liabilities | 7.3% | 6.00 | 6.00 | 7.00 | 7.00 | 6.00 | 7.00 | 6.00 | 3.00 | 2.00 | 2.00 | 4.00 | 4.00 | 7.00 | 5.00 | 3.00 | 3.00 | 5.00 | 7.00 | 7.00 | 8.00 | 7.00 |
Shareholder's Equity | 38.3% | 29.00 | 21.00 | 26.00 | 32.00 | 38.00 | 44.00 | 51.00 | 63.00 | 66.00 | 2.00 | 1.00 | 1.00 | 2.00 | 2.00 | 1.00 | 2.00 | - | 7.00 | 14.00 | 21.00 | 29.00 |
Retained Earnings | -6.1% | -104 | -98.44 | -92.41 | -85.63 | -79.10 | -72.79 | -65.50 | -333 | -330 | -58.90 | -327 | -324 | -322 | -319 | -318 | -316 | -313 | -304 | -296 | -289 | -280 |
Additional Paid-In Capital | 11.8% | 133 | 119 | 119 | 118 | 8.00 | 117 | 8.00 | 49.00 | 49.00 | 7.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 48.00 | 47.00 | 47.00 |
Shares Outstanding | - | 55.00 | - | - | - | 51.00 | - | - | - | 13.00 | 37.00 | 8.00 | 13.00 | 9.00 | - | 7.00 | 8.00 | - | - | - | - | - |
Float | - | - | - | - | 39.00 | - | - | - | 57.00 | - | - | - | 146 | - | - | - | 13.00 | - | - | - | 33.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -29.6% | -4,512 | -3,481 | -7,702 | -5,550 | -6,966 | -5,203 | -6,959 | -3,449 | -3,176 | -2,959 | -3,029 | -4,185 | -778 | -1,453 | -1,478 | -5,237 | -8,654 | -7,386 | -6,458 | -6,635 | -7,150 |
Share Based Compensation | -23.3% | 353 | 460 | 511 | 524 | 369 | 361 | 392 | 13.00 | 340 | 838 | 390 | 19.00 | 19.00 | 27.00 | 27.00 | 88.00 | 279 | 482 | 686 | 859 | 898 |
Cashflow From Investing | 75.5% | -182 | -743 | -63.00 | -44.00 | -37.00 | -41.00 | -181 | -86.00 | -30.00 | -256 | - | - | - | 1.00 | 398 | - | -331 | -99.00 | -230 | -127 | -37.00 |
Cashflow From Financing | 59421.7% | 13,690 | 23.00 | 103 | 7.00 | - | - | 55,377 | 12.00 | 8,001 | 4,217 | -68,211 | 51,148 | 24,466 | 2,200 | - | 6,403 | -5.00 | 352 | - | 238 | 34,399 |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development, net of grants | $ 3,726 | $ 3,955 |
General and administrative, net of grants | 2,501 | 2,646 |
Total operating expenses | 6,227 | 6,601 |
Loss from operations | (6,227) | (6,601) |
Other income, net | 188 | 283 |
Net loss | $ (6,039) | $ (6,318) |
Net loss per common share - basic and diluted | (0.12) | (0.12) |
Weighted average common shares outstanding - basic and diluted | 52,202 | 50,755 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 29,648 | $ 20,654 |
Prepaid expenses and other current assets | 1,854 | 2,408 |
Total current assets | 31,502 | 23,062 |
Property and equipment, net | 1,689 | 1,729 |
Right-of-use assets | 19,212 | 19,616 |
Restricted cash | 1,338 | 1,338 |
Other assets | 47 | 52 |
Total assets | 53,788 | 45,797 |
Current liabilities: | ||
Accounts payable | 570 | 542 |
Accrued expenses | 1,953 | 1,727 |
Litigation accrual | 1,675 | 1,675 |
Accrued compensation expense | 506 | 396 |
Current operating lease liabilities | 1,434 | 1,383 |
Total current liabilities | 6,138 | 5,723 |
Long-term operating lease liabilities | 18,940 | 19,313 |
Total liabilities | 25,078 | 25,036 |
Stockholders’ equity: | ||
Preferred stock, par value $0.0001 per share; 10,000 shares authorized; none outstanding | ||
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 54,978 and 51,031 at March 31, 2024 and December 31, 2023, respectively | 5 | 5 |
Additional paid-in capital | 133,094 | 119,054 |
Accumulated other comprehensive income | 88 | 140 |
Accumulated deficit | (104,477) | (98,438) |
Total stockholders’ equity | 28,710 | 20,761 |
Total liabilities and stockholders’ equity | $ 53,788 | $ 45,797 |